Measures of Obesity and Co-Morbid Conditions in Maori
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00208598|
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : September 21, 2005
|Condition or disease|
This is a body composition analysis study of people self-identifying Maori and non-Maori participants from both Dunedin and Invercargill. The study consists of a clinical visit for anthropometry and oral glucose tolerance test (OGTT), followed by a single Dexa Scan visit. Participants meeting all the inclusion criteria were invited to participate in the study.
Outcome will be determined by examining Dexa Scan data and surrogate clinical endpoints. The clinical endpoints include: anthropometric measurements, Dexa analysis, bioelectric impedance, and BP measurements, and the biochemical measures of: lipid profile, fasting insulin and glucose, liver functions and uric acid levels.
|Study Type :||Observational|
|Enrollment :||220 participants|
|Observational Model:||Defined Population|
|Study Start Date :||January 2003|
|Study Completion Date :||December 2005|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00208598
|Edgar National Centre for Diabetes Research|
|Dunedin, Otago, New Zealand, 9001|
|Study Director:||Jim I Mann, FRACP, PhD||Edgar National Centre for Diabetes Research|